A new COVID-19 variant nicknamed 'razor blade throat' is causing concern due to its painful sore throat symptom. However, experts say it's not more severe than previous variants. Here's what you need to know.
The Nimbus variant is causing a stir with familiar COVID-19 symptoms and a surge in painful sore throats. Experts weigh in on its spread and vaccine efficacy. Stay informed and protected!
Merck's new drug ENFLONSIA has received FDA approval for preventing RSV in newborns and infants, promising significant reductions in hospitalizations and severe respiratory illness. This long-acting monoclonal antibody offers hope for parents facing RSV season challenges.
A recent analysis reveals a dramatic decrease in RSV-associated hospitalizations among infants aged 0-7 months during the 2024-25 season, thanks to the widespread use of maternal vaccination and nirsevimab. This significant reduction highlights the effectiveness of preventive measures and underscores the importance of early intervention.
Whooping cough cases have skyrocketed in the U.S., doubling from last year and leading to tragic deaths among young children. Experts warn that declining vaccination rates are a major factor. Learn more about the alarming rise in this preventable disease.
A hantavirus outbreak in Mammoth Lakes, California, has resulted in three tragic deaths, raising alarm among public health officials. Experts warn of increased rodent activity and the associated risks.
New analyses from CDC networks highlight the effectiveness of the 2024-25 influenza vaccine in preventing illness among children and adults. Discover how vaccination impacts flu-related hospitalizations and outpatient visits.
A child in rural West Texas becomes the first U.S. fatality in the recent measles outbreak, raising concerns about vaccination rates and public health response to preventable diseases.
